CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Ticker
- SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Planned sale Chief Scientific Officer sold 18,586 shares at $41.14 ($764,628)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Executive Officer gave up 612,549 shares (to pay taxes)
- 4 Planned sale Chief Scientific Officer sold 18,586 shares at $38.06 ($707,383)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 36,000 shares at $37.70 ($1,357,200)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director gave up 1,117 shares (to pay taxes)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
Page 3 of 29 · 572 filings